Always Remember - Buy The Dip

Sentiment Analysis For RIGL

The news is currently generally neutral for RIGL.

Based on TextBlob analysis of Yahoo! Finance news summaries for RIGL on 2015-03-27.

Yahoo! Finance News for RIGL

Why Rigel Pharmaceuticals (RIGL) Could Be Positioned for a Surge? - Tale of the Tape
Rigel Pharmaceuticals, Inc. ( RIGL ) is a Medical Drugs company that could be an interesting play for investors. That is because, not only does the stock have decent short term momentum, but it is seeing solid activity on

Rigel (RIGL) Down on Wider Q4 Loss, Revenues Increase Y/Y - Analyst Blog
Rigel Pharmaceuticals, Inc. 's RIGL fourth quarter 2014 loss of 25 cents per share was in line with the Zacks Consensus Estimate but wider than the year ago loss of 19 cents per share. Shares were down 9.3%. Rigel

Rigel Pharmaceuticals (RIGL) Shares March Higher, Can It Continue? - Tale of the Tape
As of late, it has definitely been a great time to be an investor in Rigel Pharmaceuticals, Inc. ( RIGL ) . The stock has moved higher by 39.1% in the past month, while it is also above its

Health Care Sector Update for 03/03/2015: DGX, RIGL, BOTA
Top Health care stocks JNJ flat PFE 0.3% ABT flat MRK flat AMGN 0.2% Health care shares were unchanged in pre market trade Tuesday. In health care stocks news, Quest Diagnostics Inc. ( DGX ), a provider of diagnostic

Rigel Pharma Q4 Loss Widens - Quick Facts
Rigel Pharma Q4 Loss Widens - Quick Facts

Bristol-Myers to Buy Flexus, Team Up with Rigel - Analyst Blog
Bristol Myers Squibb Company ( BMY ) is acquiring Flexus Biosciences for $1.25 billion as well as collaborating with Rigel Pharmaceuticals Inc. ( RIGL ) in a deal worth more than $339 million, all to bolster its immuno oncology

BMY, VRX Open Wallet, LLY Does It Again, RIGL Gets A Regal Touch, TRIB Is Back
BMY, VRX Open Wallet, LLY Does It Again, RIGL Gets A Regal Touch, TRIB Is Back

BMY, VRX Open Wallet, LLY Does It Again, RIGL Gets A Regal Touch, TRIB Is Back
BMY, VRX Open Wallet, LLY Does It Again, RIGL Gets A Regal Touch, TRIB Is Back

Why Shares of Rigel Pharmaceuticals Inc. Exploded Today
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes just in case they're material to our investing thesis.

Monday Sector Leaders: Drugs, Biotechnology Stocks
In trading on Monday, drugs shares were relative leaders, up on the day by about 1%. Leading the group were shares of Rigel Pharmaceuticals ( RIGL ), up about 37.3% and shares of Celldex Therapeutics ( CLDX ) up

Health Care Sector Update for 02/23/2015: RIGL, CLDX, GEVA
Top Health care stocks JNJ +0.2% PFE 0.9% ABT flat MRK +0.2% AMGN flat Health care shares were generally leaning positive in pre market trade Monday. In health care stocks news, Rigel Pharmaceuticals ( RIGL ) shares surged in

Pre-Market Most Active for Feb 23, 2015 : SLXP, HLSS, NBG, NOK, RIGL, TVIX, AAPL, OCN, SPPI, ING, SAN, SDRL
The NASDAQ 100 Pre Market Indicator is down .66 to 4,442.39. The total Pre Market volume is currently 7,740,710 shares traded. The following are the most active stocks for the pre market session Salix Pharmaceuticals, Ltd. ( SLXP )

Rigel, Bristol-Myers Collaborate For TGF Beta Receptor Kinase Inhibitors
Rigel, Bristol-Myers Collaborate For TGF Beta Receptor Kinase Inhibitors

Rigel Pharmaceuticals Will Present At J.P. Morgan Conference;Webcast At 12:00PM
Rigel Pharmaceuticals Will Present At J.P. Morgan Conference;Webcast At 12:00PM

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape
One stock that might be an intriguing choice for investors right now is Rigel Pharmaceuticals, Inc. ( RIGL ). This is because this security in the medicine space is seeing solid earnings estimate revision activity, and is in great

Rigel's R348 Fails in Phase II Study, Shares Down 13.6% - Analyst Blog
Rigel Pharmaceuticals, Inc. ( RIGL ) announced that its ophthalmic JAK SYK inhibitor, R348, failed to meet the primary and secondary endpoints in a phase II study for the treatment of dry eye disease. Rigel's shares fell 13.6% following

Sector Update: Health Care
Healthcare stocks were broadly higher Wednesday with the NYSE Healthcare Sector Index climbing about 0.8% and shares of healthcare companies in the S&P 500 advancing about 1.0% as a group. In company news, shares of Rigel Pharmaceuticals ( RIGL

Sector Update: Health Cares Stocks Posting Strong Gains; Rigel Pharma Sinks After Scrapping Eye Drug Trial
Top Healthcare Stocks JNJ +1.07% PFE +0.57% ABT +1.09% MRK +1.26% AMGN +0.59% Healthcare stocks were broadly higher Wednesday with the NYSE Healthcare Sector Index climbing about 0.8% and shares of healthcare companies in the S&P 500 advancing about

Rigel Pharmaceuticals Starts Fostamatinib Late Stage Program - Analyst Blog
Rigel Pharmaceuticals ( RIGL ) announced that it has commenced a phase III program (n=150) on its pipeline candidate fostamatinib for treating patients suffering from immune thrombocytopenic purpura (ITP), an autoimmune deficiency of the blood. Rigel Pharma intends to

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape
One stock that might be an intriguing choice for investors right now is Rigel Pharmaceuticals, Inc. ( RIGL ). This is because this security in the Medical Drugs industry space is seeing solid earnings estimate revision activity,